canyon landscape

IIT Relivion

Prospective observational study of 3 month response to external combined occipital and trigeminal neurostimulation (eCOT-NS).

The purpose of this study is to compare the responses and treatment adherence of the standard of care use of the FDA approved external combined occipital and trigeminal neurostimulation (eCOT-NS) device also called Relivion.

Status
Open and enrolling subjects.
Location
Phoenix, Arizona
Total Participants
100
Keywords
Primary Sponsor
Barrow Neurological Foundation